Recommendations for treating children with drug-resistant tuberculosis

Pharmacological Research

Volumn 105, Issue , 2016, Pages 176-182

  Galli, Luisa ^a   Lancella, Laura ^b   Garazzino, Silvia ^c   Tadolini, Marina ^d   Matteelli, Alberto ^e   Migliori, Giovanni Battista ^e   Principi, Nicola ^f   Villani, Alberto ^b   Esposito, Susanna ^f  

^a UNIVERSITY OF FLORENCE   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Anti tuberculosis drugs; Children; MDR TB; Pediatric tuberculosis; XDR TB

Indexed keywords

BEDAQUILINE; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PROTIONAMIDE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TERIZIDONE; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CHILD; CHILD HEALTH CARE; CHILDHOOD DISEASE; DRUG EFFICACY; DRUG SAFETY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HUMAN; INFECTION CONTROL; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; DRUG EFFECTS; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; PRACTICE GUIDELINE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; CHILD; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PRACTICE GUIDELINES AS TOPIC; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84956964941     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2016.01.020     Document Type: Review

References (57)

1. World Health Organization Global tuberculosis report, 2015. Geneva: World Health Organization, Geneve, Switzerland, 2015. Available at: http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059-eng.pdf?ua=1, (accessed 16.12.15).
2. H.E. Jenkins, A.W. Tolman, C.M. Yuen, J.B. Parr, S. Keshavjee, C.M. Pérez-Vélez, M. Pagano, M.C. Becerra, and T. Cohen Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates Lancet 383 2014 1572 1579
3. P.J. Dodd, E. Gardiner, R. Coghlan, and J.A. Seddon Burden of childhood tuberculosis in 22 high-burden countries: A mathematical modelling study Lancet Glob. Health 2 2014 e453 459
4. H.S. Schaaf, and B.J. Marais Management of multidrug-resistant tuberculosis in children: A survival guide for paediatricians Paediatr. Respir. Rev. 12 2011 31 38
5. J.A. Caminero Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding Int. J. Tuberc. Lung Dis. 14 2010 382 390
6. J.A. Seddon, J.J. Furin, M. Gale, H. Del Castillo Barrientos, R.M. Hurtado, F. Amanullah, N. Ford, J.R. Starke, and H.S. Schaaf Sentinel project on pediatric drug-resistant tuberculosis: caring for children with drug-resistant tuberculosis: practice-based recommendations Am. J. Respir. Crit. Care Med. 186 2012 953 964
7. L. Lancella, A. Lo Vecchio, E. Chiappini, M. Tadolini, D. Cirillo, E. Tortoli, M. de Martino, A. Guarino, N. Principi, A. Villani, S. Esposito, and L. Galli How to manage children who have come into contact with patients affected by tuberculosis J. Clin. Tuberc. Other Mycobact. Dis. 1 2015 1 12
8. A. Di Comite, S. Esposito, A. Villani, and M. Stronati Italian Pediatric TB Study Group. How to manage neonatal tuberculosis J. Perinatol. 2015 Epub August 13
9. A. Lo Vecchio, M. Bocchino, L. Lancella, C. Gabiano, S. Garazzino, R. Scotto, I. Raffaldi, LR. Assante, A. Villani, S. Esposito, A. Guarino, for the Italian Pediatric TB Study Group, Indications to hospital admission and isolation of children with possible or defined tuberculosis: systematic review and proposed recommendations for pediatric patients leaving in developed countries, Medicine (2015) in press.
10. E. Chiappini, A. Lo Vecchio, S. Garazzino, G.L. Marseglia, F. Bernardi, E. Castagnola, P. Tom, D. Cirillo, C. Russo, C. Gabiano, D. Ciofi, G. Losurdo, M. Bocchino, E. Tortoli, M. Tadolini, A. Villani, A. Guarino, and S. Esposito Italian pediatric TB study group recommendations for the diagnosis of pediatric tuberculosis Eur. J. Clin. Microbiol. Infect Dis. 2015 Epub October 17
11. N. Principi, L. Galli, L. Lancella, M. Tadolini, G.B. Migliori, A. Villani, and S. Esposito Italian pediatric TB study group recommendations concerning the first-line treatment of children with tuberculosis Paediatr. Drugs 2015 Epub November 26
12. L. Lancella, L. Galli, E. Chiappini, C. Montagnani, C. Gabiano, S. Garazzino, N. Principi, M. Tadolini, A. Matteelli, G. Battista Migliori, A. Villani, M. de Martino, and S. Esposito Italian pediatric TB study group recommendations concerning the therapeutic approach to immunocompromised children with tuberculosis Clin. Ther. 2015 Epub November 5
13. C. Montagnani, S. Esposito, L. Galli, E. Chiappini, N. Principi, and M. de Martino Italian pediatric TB study group recommendations for pediatric tuberculosis vaccination in Italy Hum. Vaccin. Immunother. 2015 Epub November 20
14. Guidelines for the planning and management of NIH Consensus Development Conferences Online Bethesda (MD). National Institutes of Health, Office of the Director, Office of Medical Applications of Research; 1993. Updated October 2001.
15. Il Programma Nazionale per le Linee Guida (PNLG). Methodological handbook-how to produce, disseminate and update clinical practice recommendations. Available at http://www.pnlg.it/en-method. (accessed 30.12.14).
16. Scottish Intercollegiate Guidelines Netwok (SIGN). available to: Available at http://www.sign.ac.uk/ (accessed 30.12.14).
17. A.E. Khan, and J.R. Starke Diagnosis of tuberculosis in children: increased need for better methods Emerg. Infect. Dis. 1 1995 115 123
18. J. Bayona, A.M. Chavez-Pachas, E. Palacios, K. Llaro, R. Sapag, and M.C. Becerra Contact investigations as a means of detection and timely treatment of persons with infectious multidrug-resistant tuberculosis Int. J. Tuberc. Lung. Dis. 7 Suppl. 3 (12) 2003 S501 S509
19. G. Sotgiu, G. Ferrara, A. Matteelli, M.D. Richardson, R. Centis, S. Ruesch-Gerdes, O. Toungoussova, J.P. Zellweger, A. Spanevello, D. Cirillo, C. Lange, and G.B. Migliori Epidemiology and clinical management of XDR-TB: A systematic review by TBNET Eur. Respir. J. 33 2009 871 881
20. M. Al-Dabbagh, K. Lapphra, R. McGloin, K. Inrig, H.S. Schaaf, B.J. Marais, L. Sauve, I. Kitai, and T.R. Kollmann Drug-resistant tuberculosis: pediatric guidelines Pediatr. Infect. Dis. J. 30 2011 501 505
21. J.A. Caminero, G. Sotgiu, A. Zumla, and G.B. Migliori Best drug treatment for multidrug-resistant and extensively-drug resistant tuberculosis Lancet Infect. Dis. 10 2010 621 629
22. C.Y. Chiang, and H.S. Schaaf Management of drug-resistant tuberculosis Int. J. Tuberc. Lung Dis. 14 2010 672 682
23. S.M. Graham Treatment of paediatric TB: revised WHO guidelines Paediatr. Respir. Rev. 12 2011 22 26
24. N.P. Poorana Ganga Devi, and S. Swaminathan Drug-resistant tuberculosis: pediatric guidelines Curr. Infect. Dis. Rep. 15 2013 356 363
25. J.A. Seddon, P. Godfrey-Faussett, A.C. Hesseling, R.P. Gie, N. Beyers, and H.S. Schaaf Management of children exposed to multidrug-resistant Mycobacterium tuberculosis Lancet Infect. Dis. 12 2012 469 479
26. World Health Organization Guidelines for treatment of tuberculosis. 4th ed. World Health Organization, Geneva, Switzerland, 2010. Available at http://www.who.int/tb/publications/2010/9789241547833/en/ (accessed 15.8.15).
27. World Health Organization Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. World Health Organization, Geneva, Switzerland, 2010. Available at: http://www.who.int/tb/features-archive/m-xdrtb-facts/en/ (accessed 16.8.15).
28. World Health Organization, Geneva, Switzerland. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Available at: http://www.who.int/tb/publications/pmdt-companionhandbook/en/ (accessed 16.8.15).
29. P. Steiner, M. Rao, M. Victoria, and M. Steiner Primary isoniazid-resistant tuberculosis in children clinical features, strain resistance, treatment, and outcome in 26 children treated at Kings County Medical Center of Brooklyn between the years 1961 and 1972 Am. Rev. Respir. Dis. 110 1974 306 311
30. J.Y. Chien, Y.T. Chen, S.G. Wu, J.J. Lee, J.Y. Wang, and C.J. Yu Treatment outcome of patients with isoniazid mono-resistant tuberculosis Clin. Microbiol. Infect. 21 2015 59 68
31. J. Rueda, T. Realpe, G.I. Mejia, E. Zapata, J.C. Rozo, B.E. Ferro, and J. Robledo Genotypic analysis of genes associated with independent resistance and cross-resistance to isoniazid and ethionamide in Mycobacterium tuberculosis clinical isolates Antimicrob. Agents Chemother. 59 2015 7805 7810
32. A. Dramowski, M.M. Morsheimer, A.M. Jordaan, T.C. Victor, P.R. Donald, and H.S. Schaaf Rifampicin-monoresistant Mycobacterium tuberculosis disease among children in Cape Town, South Africa Int. J. Tuberc. Lung. Dis. 16 2012 76 81
33. L.F. Anderson, S. Tamne, J.P. Watson, T. Cohen, C. Mitnick, T. Brown, F. Drobniewski, and I. Abubakar Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007 Euro Surveill. 2013 18 pii:20601
34. P.C. Drobac, J.S. Mukherjee, J.K. Joseph, C. Mitnick, J.J. Furin, H. del Castillo, S.S. Shin, and M.C. Becerra Community-based therapy for children with multidrug-resistant tuberculosis Pediatrics 117 2006 2022 2029
35. K. Feja, E. McNelley, C.S. Tran, J. Burzynski, and L. Saiman Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003 Pediatr. Infect. Dis. J. 27 2008 907 912
36. F. Mignone, L.R. Codecasa, C. Scolfaro, I. Raffaldi, L. Lancella, M. Ferrarese, S. Garazzino, C. Marabotto, S. Esposito, C. Gabiano, R. Lipreri, and P.A. Tovo The spread of drug-resistant tuberculosis in children: an Italian case series Epidemiol. Infect. 142 2014 2049 2056
37. A. Mukherjee, S. Singh, R. Lodha, V. Singh, A. Hesseling, H.M. Grewal, and S. Kabra Ambulatory gastric lavages provide better yields of Mycobacterium tuberculosis than induced sputum in children with intra-thoracic tuberculosis Pediat. Infect. Dis. J. 32 2013 1313 1317
38. L. Li, Z. Zhang, F. Luo, J. Xu, P. Cheng, Z. Wu, Q. Zhou, Q. He, F. Dai, J. Wang, and J. Zhang Management of drug-resistant spinal tuberculosis with a combination of surgery and individualized chemotherapy: A retrospective analysis of thirty-five patients Int. Orthop. 36 2012 277 283
39. H. Satti, M.M. McLaughlin, D.B. Omotayo, S. Keshavjee, M.C. Becerra, J.S. Mukherjee, and K.J. Seung Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence PLoS One 7 2012 e37114
40. B. Williams, S. Ramroop, P. Shah, L. Anderson, S. Das, A. Riddell, S. Liebeschuetz, R. Basu Roy, M. O'Callaghan, K. Sloper, J. Bernatoniene, D. Shingadia, and B. Kampmann Multidrug-resistant tuberculosis in UK children: presentation, management and outcome Eur. Respir. J. 41 2013 1456 1458
41. D. Ettehad, H.S. Schaaf, J.A. Seddon, G.S. Cooke, and N. Ford Treatment outcomes for children with multidrug-resistant tuberculosis: A systematic review and meta-analysis Lancet Infect. Dis. 12 2012 449 456
42. J.V. Chauny, M. Lorrot, S. Prot-Labarthe, A. De Lauzanne, C. Doit, T. Géréral, and O. Bourdon Treatment of tuberculosis with levofloxacin or moxifloxacin: report of 6 pediatric cases Pediatr. Infect. Dis. J. 31 2012 1309 1311
43. S. Garazzino, L. Galli, E. Chiappini, M. Pinon, B.M. Bergamini, S. Cazzato, P. Dal Monte, I. Dodi, L. Lancella, S. Esposito, L. Iughetti, C. Montagnani, M. De Martino, P.A. Tovo, and SITIP IGRA Study Group Performance of interferon- release assay for the diagnosis of active or latent tuberculosis in children in the first 2 years of age: A multicenter study of the Italian Society of Pediatric Infectious Diseases Pediatr. Infect. Dis. J. 33 2014 e226 e231
44. H.S. Schaaf, M. Willemse, and P.R. Donald Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis BMC Med. 7 2009 19
45. H.A. Anger, F. Dworkin, S. Sharma, S.S. Munsiff, D.M. Nilsen, and S.D. Ahuja Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06 J. Antimicrob. Chemother. 65 2010 775 783
46. R. Condos, N. Hadgiangelis, E. Leibert, G. Jacquette, T. Harkin, and W.N. Rom Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis Chest 134 2008 187 192
47. S. Garazzino, and P.A. Tovo Clinical experience with linezolid in infants and children J. Antimicrob. Chemother. 66 2011 23 41
48. C. Garcia Vidal, S. Rodríguez Fernández, J. Martínez Lacasa, M. Salavert, R. Vidal, M. Rodríguez Carballeira, and J. Garau Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis Clin. Infect. Dis. 40 2005 756 759
49. P. Kjöllerström, M.J. Brito, C. Gouveia, G. Ferreira, and L. Varandas Linezolid in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis in paediatric patients: experience of a paediatric infectious diseases unit Scand. J. Infect. Dis. 43 2011 556 559
50. P.C. Rose, U.M. Hallbauer, J.A. Seddon, A.C. Hesseling, and H.S. Schaaf Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children Int. J. Tuberc. Lung Dis. 16 2012 1588 1593
51. Centers for Disease Control and Prevention Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis. MMWR Recomm Rep 2013;62(RR-09):1-12. Erratum in: MMWR Recomm Rep 2013;62:906.
52. S. Esposito, S. Bianchini, and F. Blasi Bedaquiline and delamanid in tuberculosis Expert Opin. Pharmacother. 2015 Epub August 21
53. S. Esposito, L. D'Ambrosio, M. Tadolini, H.S. Schaaf, J. Caminero Luna, B. Marais, R. Centis, M. Dara, A. Matteelli, F. Blasi, and G.B. Migliori ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use Eur. Respir. J. 44 2014 811 815
54. N. Alsaad, B. Wilffert, R. van Altena, W.C. de Lange, T.S. van der Werf, J.G. Kosterink, and J.W. Alffenaar Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis Eur. Respir. J. 43 2014 884 897
55. R. Panchagnula, P. Sancheti, S. Rungta, S. Agrawal, and C.L. Kaul Evaluation of bioequivalence of isoniazid and pyrazinamide in three and four drugs fixed dose combinations using WHO simplified protocol Pharmacol. Res. 48 2003 383 387
56. B. Tunçtan, H. Okur, C.H. Calişir, H. Abacioʇlu, I. Cakici, I. Kanzik, and N. Abacioʇlu Comparison of nitric oxide production by monocyte/macrophages in healthy subjects and patients with active pulmonary tuberculosis Pharmacol. Res. 37 1998 219 226
57. J. Yue, R. Peng, J. Chen, Y. Liu, and G. Dong Effects of rifampin on CYP2E1-dependent hepatotoxicity of isoniazid in rats Pharmacol. Res. 59 2009 112 119